John Behman, Physician at Duke Department of Medicine, shared a post on LinkedIn:
“Incredibly excited to have been selected to present Abstracts 1948 ‘Characterizing differences in CAR-T cell therapy outcomes based on sex in patients with large B-cell lymphoma.’ and 6084 at ASH25 in Orlando ‘Novel machine learning (ML) and traditional statistical techniques in survival analysis of real-world data for allogeneic hematopoietic cell transplantation (HCT) consolidation in patients with acute lymphoblastic leukemia (ALL)’.
Thank you so much for the incredible support to the incredible mentorship of M. Bilal Abid and Taiga Nishihori.”
More posts about ASH25.